• President Donald Trump is set to be discharged from Walter Reed National Military Medical Center on Monday after his condition improved significantly following treatments, his doctors said.
  • Trump tested positive for COVID-19 late last week, though a precise timeline of his infection remains unclear.
  • Before the doctors spoke to reporters, Trump tweeted that he would get out of the hospital at 6:30 p.m.
  • Dr. Sean Conley, the White House physician, did not answer questions about Trump’s test results or whether Trump was contagious.
  • Visit Business Insider’s homepage for more stories.

President Donald Trump is set to head back to the White House on Monday after being cleared by his doctors.

In a press briefing, Trump’s doctors said his condition had rapidly improved during his stay at Walter Reed National Military Medical Center and following several therapeutic COVID-19 treatments.

Dr. Sean Conley, the White House physician, said that while the president

Read More


Stocks jumped Monday afternoon after President Donald Trump announced he would be discharged from Walter Reed Medical Center by day’s end, with all of the main indexes adding close to 2%, as Wall Street eyes President Trump’s Covid-19 recovery and the ongoing potential for successful stimulus negotiations.

Key Facts

The Dow Jones Industrial Average jumped 460 points, or 1.7%, while the S&P 500 added 1.8%, and the tech-heavy Nasdaq climbed 2.3%.

Fantasy sports betting firm DraftKings fell 6% after announcing a public offering of 32 million Class A shares, which closed Monday trading priced at $60.55.

Bristol Myers Squibb said Monday it is acquiring Brisbane, Calif.-based MyoKardia, a clinical stage biopharmaceutical company, for $225 per share–a more than 60% premium to its Friday closing price–in a transaction valued at roughly $13.1 billion.

BridgeBio Pharma Inc. announced Monday morning that

Read More

President Donald Trump could be discharged from the hospital where he is being treated for Covid-19 as soon as Monday, according to his doctors, although his condition remains unclear and outside experts warn that his case may be severe.

Sequestered at Walter Reed National Military Medical Centre outside Washington since Friday, Trump has released a series of videos in an effort to reassure the public that he is recovering from a pandemic that has infected 7.4 million Americans and killed more than 209,000.

“It’s a very interesting journey. I learned a lot about COVID,” he said in a video posted to Twitter on Sunday.

A return to the White House might help Trump project a sense of normalcy as he faces a difficult re-election battle against Democrat Joe Biden.

A Reuters/Ipsos poll released on Sunday showed Trump trailing Biden by 10 percentage points. About 65 per cent of Americans said

Read More

TAIPEI and SAN DIEGO, Sept. 11, 2020 /PRNewswire/ — Senhwa Biosciences, Inc. (TPEx: 6492), a clinical-stage biopharmaceutical company focused on next generation DNA Damage Response (DDR) therapeutics for the treatment of cancer, announced today that the first patient with severe COVID-19 demonstrated remarkable recovery after treatment with the Company’s investigational drug, Silmitasertib.

On August 27, 2020, the Food and Drug Administration (FDA) approved the first emergency IND and authorized use of Silmitasertib in a patient with severe COVID-19 pneumonia requiring supplemental oxygen. The patient had been treated with multiple therapeutics, including Remdesivir, Dexamethasone, Ceftriaxone, Azithromycin and Enoxaparin within two weeks, but remained hypoxic and required up to 2 liters of supplemental oxygen daily. As none of the available therapeutics worked well for this patient, the investigator decided to try Senhwa’s investigational drug, Silmitasertib.  Within 24 hours of the first dose the patient showed significant clinical improvement and the

Read More